Printed From BioPortfolio.com
DNA mutations shed in blood predicts response to immunotherapy in patients with cancer
20:00 EDT 1 Oct 2017 | AAAS
(University of California - San Diego) In a first-of-its-kind study, University of California San Diego School of Medicine researchers report that a blood sample, or liquid biopsy, can reveal which patients will respond to checkpoint inhibitor-based immunotherapies.
Original Article: DNA mutations shed in blood predicts response to immunotherapy in patients with cancer
